NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Upstream Bio, Inc. Common Stock Share Price Chart

O H L

Upstream Bio, Inc. Common Stock Performance Overview

Days Range
$5.21Low
$5.32High

Markets Today

Previous Close$5.31
Open$5.32
Volume55,315
Day's Range$5.21 - $5.32
52W RangeNA
Market Cap$291.93 M

Historical Performance

1M Returns-22.48
3M Returns-15.04
6M Returns-38.72
1Y Returns-69.25
5Y ReturnsNA
10Y ReturnsNA

Upstream Bio, Inc. Common Stock Fundamentals

Market Cap$291.93 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$2.85 M
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-160.17 M
Profit Margin-5026.03
Market Cap$291.93 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$2.85 M
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-160.17 M
Profit Margin-5026.03

Upstream Bio, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$566.00 K$937.00 K$683.00 K$668.00 K$1.03 M$773.00 K
Gross Profit +$566.00 K$937.00 K$683.00 K$668.00 K$1.03 M$773.00 K
Operating Income -$32.01 M-$44.35 M-$37.83 M-$46.17 M-$43.62 M-$42.37 M
EBITDA -$31.97 M-$44.30 M-$37.79 M-$46.11 M-$43.57 M-$42.32 M
Interest Expense $0$0$0$0$0$0
Depreciation $43.00 K$42.00 K$46.00 K$57.00 K$49.00 K$50.00 K
Income Before Tax -$27.27 M-$39.97 M-$33.75 M-$42.46 M-$40.59 M-$39.70 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$27.27 M-$39.97 M-$33.75 M-$42.46 M-$40.59 M-$39.70 M
Net Profit Margin -4818.02%-4265.31%-4941.14%-6356.14%-3925.63%-5136.09%

Upstream Bio, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $53.00 K$54.00 K$56.00 K$54.00 K$54.00 K$54.00 K
Reserve & Surplus -$217.68 M-$257.76 M-$291.27 M-$333.69 M-$374.71 M-$414.64 M
Non-Current Liabilities $992.00 K$849.00 K$703.00 K$549.00 K$390.00 K$226.00 K
Current Liabilities $9.57 M$10.93 M$11.91 M$13.45 M$13.67 M$9.99 M
Total Liabilities $10.56 M$11.78 M$12.61 M$14.00 M$14.06 M$10.21 M
Fixed Assets $539.00 K$544.00 K$616.00 K$559.00 K$510.00 K$460.00 K
Current Assets $453.79 M$418.27 M$389.02 M$351.80 M$316.28 M$279.60 M
Total Assets $456.17 M$420.52 M$391.19 M$353.77 M$318.05 M$281.17 M

Upstream Bio, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$27.27 M-$39.97 M-$33.75 M-$42.46 M-$40.59 M-$39.70 M
Operating Cash Flow -$41.16 M-$39.24 M-$22.24 M-$30.63 M-$47.85 M-$35.62 M
Investing Cash Flow -$213.38 M$12.77 M$48.19 M$58.94 M$42.40 M$15.76 M
Financing Cash Flow -$34.00 K$612.00 K$760.00 K$1.10 M$598.00 K$2.53 M
Change in Cash -$254.58 M-$25.85 M$26.71 M$29.41 M-$4.85 M-$17.33 M

Upstream Bio, Inc. Common Stock Return Calculator

The Upstream Bio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Upstream Bio, Inc. Common Stock

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases. Verekitug has advanced into three separate world-wide, placebo-controlled, randomized Phase 2 clinical trials, two completed in chronic rhinosinusitis with nasal polyps (CRSwNP) and severe asthma, and one ongoing in chronic obstructive pulmonary disease (COPD).

FAQs

Upstream Bio, Inc. Common Stock (UPB) share price as of September 18, 2026 is $5.26. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Upstream Bio, Inc. Common Stock (UPB) Share by opening an international trading account with Angel One.
Purchasing Upstream Bio, Inc. Common Stock (UPB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Upstream Bio, Inc. Common Stock (UPB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Upstream Bio, Inc. Common Stock (UPB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Upstream Bio, Inc. Common Stock on September 18, 2026, is $291.93 M.
Upstream Bio, Inc. Common Stock operates in the null sector, specifically in the null industry.
In order to invest in Upstream Bio, Inc. Common Stock (UPB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91